Fluoxetine disrupts motivation and GABAergic signaling in adolescent female hamsters

Abstract

Initial antidepressant treatment can paradoxically worsen symptoms in depressed adolescents by undetermined mechanisms. Interestingly, antidepressants modulate GABAA receptors, which mediate paradoxical effects of other therapeutic drugs, particularly in females. Although the neuroanatomic site of action for this paradox is unknown, elevated GABAA receptor signaling in the nucleus accumbens can disrupt motivation. We assessed fluoxetine's effects on motivated behaviors in pubescent female hamsters - anhedonia in the reward investigational preference (RIP) test as well as anxiety in the anxiety-related feeding/exploration conflict (AFEC) test. We also assessed accumbal signaling by RT-PCR and electrophysiology. Fluoxetine initially worsened motivated behaviors at puberty, relative to adulthood. It also failed to improve these behaviors as pubescent hamsters transitioned into adulthood. Low accumbal mRNA levels of multiple GABAA receptor subunits and GABA-synthesizing enzyme, GAD67, assessed by RT-PCR, suggested low GABAergic tone at puberty. Nonetheless, rapid fluoxetine-induced reductions of α5GABAA receptor and BDNF mRNA levels at puberty were consistent with age-related differences in GABAergic responses to fluoxetine and disruption of the motivational state. Whole-cell patch clamping of accumbal slices also suggested low GABAergic tone by the low amplitude of miniature inhibitory postsynaptic currents (mIPSCs) at puberty. It also confirmed age-related differences in GABAergic responses to fluoxetine. Specifically, fluoxetine potentiated mIPSC amplitude and frequency at puberty, but attenuated the amplitude during adulthood. These results implicate GABAergic tone and GABAA receptor plasticity in adverse motivational responses and resistance to fluoxetine during adolescence.

Neuromodulatory Control of Long-Term Behavioral Patterns and Individuality across Development

“…Further analysis of behavioral consistency appears in Figure S5. adolescent and adult hamsters (Shannonhouse et al, 2016), and the use of this class of compounds in human adolescents has raised concerns (Jane Garland et al, 2016). Our studies suggest that examining the developmental regulation of behavior by neuromodulatory systems is a promising area for further exploration.…”

Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury

“…Considering their primarily clinical roles as antidepressants, both buspirone and fluoxetine are likely to act on circuits underlying motivation. They can differentially modulate motivated behaviors depending on its dose and context [42][43][44][45][46][47]. Motivation can highly affect motor performance.…”

Opinion paper: poor response to treatment of depression in people in high occupational levels

“…Because of the anticholinergic and histaminergic effects common to many tricyclic antidepressants, reduced cognitive function may be felt early in treatment, before the therapeutic effects which comes later. Serotoninergic agents, because of their anti-anxiety properties, can impair the evaluation of critical aspects of situations and reduce motivation levels (McCabe et al ., 2010; Marutani et al ., 2011; Shannonhouse et al ., 2016). It has been reported that the detachment effect induced by many medications for depression such as serotoninergic inhibitors may be troublesome for some individuals (Harmer, 2008; Serretti et al ., 2010).…”